A research team from the University of Otago, Wellington (UOW) in New Zealand has received a $1m MBIE Endeavour grant to develop a non-invasive device for the diagnosis and treatment of stroke and brain injuries.

Contrary to current invasive or expensive technologies such as imaging equipment to detect lack of oxygen to the brain, the new device is intended to be safe, cheap and quick.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Led by associate professor Shieak Tzeng, the new research will be based on previous work, which demonstrated that the team’s concept based on portable magnetic resonance technology could detect changes in blood oxygen levels.

Professor Tzeng said: “Brain tissue is exceptionally vulnerable to ischemia (lack of oxygen), so early detection and targeted therapy are crucial to improving survival rates across a wide range of conditions.”

The researchers aim to design new sensors with the ability to identify a wide range of brain injury biomarkers, including tissue diffusion and perfusion.

"The researchers aim to design new sensors with the ability to identify a wide range of brain injury biomarkers, including tissue diffusion and perfusion."

To be designed and built in the country, the new device is expected to deliver a complete picture of brain injury processes to allow targeted treatments.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Tzeng further added: “We will design it in partnership with those New Zealand’s health professionals who will be using it as well as the NZ biotechnology industry to make the device accessible worldwide.

“We have a vision of New Zealand export sales of medical devices that enable comprehensive brain monitoring at the point-of-care.”

It is expected that the ability of the device to detect the common brain injury mechanism, ischemia, will enable treatment of various neurovascular disorders.

Image: UOW associate professor Shieak Tzeng. Photo: courtesy of the University of Otago, Wellington, New Zealand.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact